We expect Affordable Care Act (ACA) health insurance and pricing effects to reduce real demand growth by roughly 30bp over the period from 2012 – 2021 Medicaid should expand to 100 FPL in most states; this translates to enrollment gains
All of the economic signals we see in the market today support the idea that demand growth is slow and is slowing globally. China appears to be at a standstill, despite recent stimulus moves and slowly companies are realizing that
We expect 3.9% y/y health services demand growth during 3Q/12, the product of 1.9% growth in unit demand and 2.0% growth in pricing. This marks a 10bp increase over our initial 3Q12 estimate, the net of a 20bp lower unit
In recent work on gross margin trajectories for US Industrials and Basic Industries, we can’t help but be impressed by the positive and stable growth in gross margins for the Industrials group. We were less impressed (but not surprised) by
The ISM numbers today again support our view that slowing demand is likely to cut significantly into second half earnings and in many cases drive some significant surprises or revisions. Given that this coincides with a period of very high
This note quantifies a ‘baseline’ rate of real growth in US healthcare demand, which we define as the rate of growth one would expect sans any upcoming secular, cyclical, or reform effects We estimate baseline growth of 4.8% +/- 0.9%
In recent work we have looked at the M&A landscape for industrials and concluded that we expect to see a sharp increase in the number of deals and an increase in the values paid. This week we saw Hertz agree